R. Westhovens

Validation of a simple activity participation measure for rheumatoid arthritis clinical trials (2009)

Li, T., Wells, G., Westhovens, R., Tugwell, P.

Objective. To examine the validity, reliability and sensitivity to change of the Activity Participation Questionnaire (APaQ), a simple measure of activity participation for patients with RA. Methods....

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population (2008)

Vander Cruyssen, Bert, WESTHOVENS, R, DUREZ, P, DE CLERCK, L, PERETZ, A, VERBRUGGEN, L, ...

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population (2008)

Vander Cruyssen, Bert, WESTHOVENS, R, DUREZ, P, VAN DEN BOSCH, FILIP, Mielants, Herman, DE CLERCK, L, ...

Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis (2008)

Verschueren, P., Esselens, G., Westhovens, R.

Objective. To study prospectively the daily practice effectiveness of a step-down early rheumatoid arthritis (RA) treatment strategy. Methods. Patients with severe RA and no contra-indications were...

Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate (2008)

Vera-Llonch, M., Massarotti, E., Wolfe, F., Shadick, N., Westhovens, R., Sofrygin, O., ...

Objective. To assess cost–effectiveness of abatacept in patients with moderately to severely active RA and inadequate response to MTX. Methods. We developed a simulation model to depict progression...

A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip (2007)

Luyten, F. P., GEUSENS, Piet, Malaise, M., De Clerck, L., Westhovens, R., Raeman, F., ...

Objective: To compare the effects of continuous and intermittent celecoxib treatment in patients with knee or hip osteoarthritis in flare. Methods: In this 24-week, prospective, randomised,...

A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip (2007)

Luyten, F. P., GEUSENS, Piet, Malaise, M., De Clerck, L., Westhovens, R., Raeman, F., ...

Objective: To compare the effects of continuous and intermittent celecoxib treatment in patients with knee or hip osteoarthritis in flare. Methods: In this 24-week, prospective, randomised,...

A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip (2007)

LUYTEN, FP, GEUSENS, P, MALAISE, M, DE CLERCK, L, WESTHOVENS, R, RAEMAN, F, ...

The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo-controlled trial (2006)

Westhovens, R., Yocum, D., Han, J., Berman, A., Strusberg, I., ...

OBJECTIVE: To assess the risk of serious infections following 22 weeks of infliximab therapy, and to further characterize the safety profile of infliximab in combination with background treatments...

The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo-controlled trial (2006)

Westhovens, R., Yocum, D., Han, J., Berman, A., Strusberg, I., ...

OBJECTIVE: To assess the risk of serious infections following 22 weeks of infliximab therapy, and to further characterize the safety profile of infliximab in combination with background treatments...

The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo-controlled trial (2006)

Westhovens, R., Yocum, D., Han, J., Berman, A., Strusberg, I., GEUSENS, Piet, ...

OBJECTIVE: To assess the risk of serious infections following 22 weeks of infliximab therapy, and to further characterize the safety profile of infliximab in combination with background treatments...

Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition (2006)

Vander Cruyssen, Bert, WESTHOVENS, R, DUREZ, P, Van Den Bosch, Filip, Mielants, Herman, DE CLERCK, L, ...

Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity (2006)

Vander Cruyssen, Bert, Van Looy, Stijn, Wyns, Bart, WESTHOVENS, R, DUREZ, P, Van Den Bosch, Filip, ...

Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment (2006)

Van Looy, Stijn, Vander Cruyssen, Bert, Meeus, Jeroen, Wyns, Bart, WESTHOVENS, R, DUREZ, P, ...

THE EXPERT PATIENT'S GUIDE TO LIVING A FULL LIFE WITH RHEUMATOID ARTHRITIS. By Jasmine Jenkins. {pound}9.99. Howtobooks, Oxford, 2005. 158 pp. ISBN 1-84528-032-6. (2006)

Westhovens, R.

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial (2006)

Westhovens, R., Cole, J. C., Li, T., Martin, M., MacLean, R., Lin, P., ...

Objective. Rheumatoid arthritis (RA) patients who have inadequate response to anti-tumour necrosis factor (TNF) therapy currently have treatment options that are limited and less than optimal in...

Book Review (2006)

Westhovens, R.

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial (2006)

Westhovens, R., Cole, J. C., Li, T., Martin, M., MacLean, R., Lin, P., ...

Objective. Rheumatoid arthritis (RA) patients who have inadequate response to anti-tumour necrosis factor (TNF) therapy currently have treatment options that are limited and less than optimal in...

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial (2006)

Westhovens, R., Cole, J. C., Li, T., Martin, M., MacLean, R., Lin, P., ...

Objective. Rheumatoid arthritis (RA) patients who have inadequate response to anti-tumour necrosis factor (TNF) therapy currently have treatment options that are limited and less than optimal in...

Book Review (2006)

Westhovens, R.

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment (2005)

Cruyssen, B, Van Looy, S, Wyns, B, Westhovens, R, Durez, P, Malaise, M, ...

This study is based on an expanded access program in which 511 patients suffering from active refractory rheumatoid arthritis (RA) were treated with intravenous infusions of infliximab (3 mg/kg+...

Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients (2005)

Vander Cruyssen, Bert, Van Looy, Stijn, WESTHOVENS, R, DUREZ, P, Van Den Bosch, Filip, VEYS, EM, ...

Healthcare consumption and direct costs of rheumatoid arthritis in Belgium (2005)

WESTHOVENS, R, BOONEN, A, VERBRUGGEN, L, DUREZ, P, DE CLERCK, L, MALAISE, M, ...

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment (2005)

Vander Cruyssen, Bert, Van Looy, Stijn, Wyns, Bart, WESTHOVENS, R, DUREZ, P, MALAISE, M, ...

DAS28 is a robust measure of the physician's clinical judgment of response infliximab therapy (2005)

Vander Cruyssen, Bert, Van Looy, Stijn, Wyns, Bart, WESTHOVENS, R, DUREZ, P, ...

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study (2005)

Durez, P., Corluy, L., Veys, E. M., De Clerck, L., Peretz, A., ...

Objectives. To analyse the effect of a dose increase in patients with severe rheumatoid arthritis (RA) with insufficient clinical response to 3 mg/kg infliximab every 8 weeks. Methods. Patients...

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study (2005)

Durez, P., Corluy, L., Veys, E. M., Clerck, L. De, Peretz, A., ...

Objectives. To analyse the effect of a dose increase in patients with severe rheumatoid arthritis (RA) with insufficient clinical response to 3 mg/kg infliximab every 8 weeks. Methods. Patients...

Timing of DAS28 in infliximab therapy: reply (2005)

Durez, P., Corluy, L., Veys, E., De Clerck, L., Peretz, A., ...

Timing of DAS28 in infliximab therapy: reply (2005)

Durez, P., Corluy, L., Veys, E., De Clerck, L., Peretz, A., ...

Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment (2004)

Westhovens, R, Van Riel, P, Sibilia, J, Vratsanos, G, Nuamah, I, Becker, JC

No abstract available.

The safety and efficacy of infliximab in RA: 1-year results of a large, randomized, placebo-controlled trial in patients with various comorbidities and background treatments as encountered in clinical practice. (2004)

Yocum, D, Wolfe, F, Rahman, MU, Han, J, Berman, A, Strusberg, I, ...

Univ Arizona, Tucson, AZ USA. Natl Data Bank Rheum Dis, Wichita, KS USA. Centocor Inc, Malvern, PA 19355 USA. Hosp Angel C Padilla, San Miguel De Tucuman, Argentina. Ctr Reumatol Strusberg, Cordoba,...

The safety and efficacy of infliximab in RA: 1-year results of a large, randomized, placebo-controlled trial in patients with various comorbidities and background treatments as encountered in clinical practice. (2004)

Yocum, D, Wolfe, F, Rahman, MU, Han, J, Berman, A, Strusberg, I, ...

Univ Arizona, Tucson, AZ USA. Natl Data Bank Rheum Dis, Wichita, KS USA. Centocor Inc, Malvern, PA 19355 USA. Hosp Angel C Padilla, San Miguel De Tucuman, Argentina. Ctr Reumatol Strusberg, Cordoba,...

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids - A randomized, double-blind, placebo-controlled extension trial. (2001)

ADACHI, JD, SAAG, KG, DELMAS, PD, LIBERMAN, UA, EMKEY, RD, SEEMAN, E, ...

Prognostic factors and outcome in rheumatoid arthritis / (1999)

Westhovens, R.

Thesis (doctoral)--Katholieke Universiteit Leuven, 1999.

Diagnostiek van osteoporose. (1997)

DEVOGELAER, J, REGINSTER, J, RAEMAN, F, WESTHOVENS, R, ROZENBERG, S, BODY, J, ...

Prevention and treatment of postmenopausal osteoporosis. National consensus of the 'Belgian Bone Club (1997)

Kaufman, Jean, DEVOGELAER, J, RAEMAN, F, ROZENBERG, S, BODY, J, WESTHOVENS, R, ...

Body composition in rheumatoid arthritis (1997)

Westhovens, R, Nijs, J, Taelman, V, Dequeker, J

INVERSE RELATIONSHIP OSTEOARTHRITIS--OSTEOPOROSIS: WHAT IS THE EVIDENCE? WHAT ARE THE CONSEQUENCES? (1996)

DEQUEKER, J., BOONEN, S., AERSSENS, J., WESTHOVENS, R.

STEROID MYOPATHY INDUCED BY EPIDURAL TRIAMCINOLONE INJECTION (1995)

BOONEN, S., VAN DISTEL, G., WESTHOVENS, R., DEQUEKER, J.

Epidural steroid injections are widely used for the treatment of lumbago and sciatica although their efficacy has not yet been demonstrated in a convincing way. Moreover, systemic complications,...

Distinction between initiation and progression of the osteoarthritis process.

Dequeker, J, Westhovens, R

Vertebral fracture induced by chronic contained rupture of aortic aneurysm.

Boonen, A, Ghesquiere, B, Westhovens, R, Geusens, P, Dequeker, J, Boonen, S

Clinical and immunogenetic characteristics of European multicase rheumatoid arthritis families

Balsa, A, Barrera, P, Westhovens, R, Alves, H, Maenaut, K, Pascual-Salcedo, D, ...

OBJECTIVE—To describe the characteristics of a new set of European families with affected sib pairs (ASP) collected by the European Consortium on Rheumatoid Arthritis Families (ECRAF) to replicate...

Benefit of anti-TNFα treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis

Verschueren, P, Lensen, F, Lerut, E, Claes, K, De Vos, R, Van Damme, B, ...

Diagnostic characteristics of a gelatin based Waaler-Rose assay (Serodia-RA) for the detection of rheumatoid factor

Spiritus, T, Verschueren, P, Westhovens, R, Bossuyt, X

Methods: RF was measured by Serodia-RA and rate nephelometry in 90 patients with RA according to the revised ACR criteria and 102 patients with rheumatological diseases other than RA. Sensitivity,...

A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment

Durez, P, Nzeusseu, T, Lauwerys, B, Manicourt, D, Verschueren, P, Westhovens, R, ...

Objectives: To compare the short term clinical and biological effects of intravenous (IV) pulse methylprednisolone (MP) and infliximab (IFX) in patients with severe active rheumatoid arthritis (RA)...

Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA?

Buttgereit, F, Burmester, G, Bijlsma, J, Durez, P, Nzeusseu, T, Lauwerys, B, ...

Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails?

Smith, M, Durez, P, Nzeusseu, T, Lauwerys, B, Manicourt, D, Devogelaer, J, ...

A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis

Fraser, A, Westhovens, R, Karim, Z, Wakefield, R, Gerards, A, ...

Objectives: To evaluate the safety and efficacy of adding ciclosporin A (CSA) to the treatment of patients with psoriatic arthritis (PsA) demonstrating an incomplete response to methotrexate (MTX)...

Recovery without sequelae from severe methanol intoxication

Martens, J., Verberckmoes, R., Westhovens, R., Delooz, H., Daenens, P.

A case of massive methanol poisoning is described. The peak serum methanol level of 287·5 mmol/litre (920 mg/dl) is by far the highest recorded level associated with complete recovery. This...

Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial

Genant, H K, Peterfy, C G, Westhovens, R, Becker, J-C, Aranda, R, Vratsanos, G, ...

Orthopaedic surgery in patients with rheumatoid arthritis: a shift towards more frequent and earlier non‐joint‐sacrificing surgery

Boonen, A, Matricali, G A, Verduyckt, J, Taelman, V, Verschueren, P, Sileghem, A, ...

Personal attributes as determinants of timely care in rheumatoid arthritis

Esselens, G H, De Brabander, A, Ovaere, L, De Brabanter, G, Moons, P, Westhovens, R

Genetic variation in the TNFRSF11A (RANK) gene contributes to the risk to develop sporadic Paget's disease of bone

Chung, P. Y. J., Beyens, G., Riches, P. L., Van Wesenbeeck, L., Jennes, K., Daroszewska, A., ...

[Chung, P. Y. J.; Beyens, G.; Van Wesenbeeck, L.; Jennes, K.; Van Hul, W.] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium. [Chung, P. Y. J.; Beyens, G.; Van Wesenbeeck, L.; Jennes, K.; Van...

The presence of forefoot problems and the role of surgery in patients with rheumatoid arthritis

Matricali, G A, Boonen, A, Verduyckt, J, Taelman, V, Verschueren, P, Sileghem, A, ...